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Introduction
Regulation of renal sodium (Na+) handling is a key
determinant in the long-term control of extracellular fluid
volume homeostasis. Na+-resorption is mediated via the
amiloride-sensitive epithelial sodium channel (ENaC) that
exhibits high selectivity for sodium [1] and is a central
requirement for Na+-resorption across renal epithelia.
ENaC expression and translocation to the plasma-
membrane is tightly regulated by a diverse array of
hormonal [2-5] and physical factors [6, 7]. Key in the
regulation of ENaC function is the serum and
glucocorticoid-regulated kinase (SGK1). SGK1 is known
Abstract
Background/Aim: Diabetic nephropathy is associated
with progressive renal damage, leading to impaired
function and end-stage renal failure. Secondary
hypertension stems from a deranged ability of cells
within the kidney to resolve and appropriately regulate
sodium resorption in response to hyperglycaemia.
However, the mechanisms by which glucose alters
sodium re-uptake have not been fully characterised.
Methods: Here we present RT-PCR, western blot and
immunocytochemistry data confirming mRNA and
protein expression of the serum and glucocorticoid
inducible kinase (SGK1) and the α conducting subunit
of the epithelial sodium channel (ENaC) in a model in
vitro system of the human cortical collecting duct
(HCD). We examined changes in expression of these
elements in response to glucose challenge, designed
to mimic hyperglycaemia associated with type 2
diabetes mellitus. Changes in Na+ concentration were
assessed using single-cell microfluorimetry. Results:
Incubation with glucose, the Ca2+-ionophore ionomycin
and the cytokine TGF-β1 were all found to evoke
significant and time-dependent increases in both
SGK1 and αENaC protein expression. These
molecular changes were correlated to an increase in
Na+-uptake at the single-cell level. Conclusion:
Together these data offer a potential explanation for
glucose-evoked Na+-resorption and a potential
contributory role of SGK1 and ENaCs in development
of secondary hypertension, commonly linked to
diabetic nephropathy.
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to phosphorylate the neural precursor cell expressed
developmentally down-regulated ubiquitin protein ligase
Nedd 4.2 [8, 9]. Normally bound to the ENaC in its
unphosphorylated form, SGK1-mediated phosphorylation
causes Nedd 4.2 to release ENaC to the membrane
consequently allowing for increased Na+-uptake. These
mechanisms partially explain immediate increases in
transepithelial sodium uptake in response to acute, but
physiologically appropriate stimuli. Longer-term regulation
is likely to be dependent on the de novo synthesis of both
SGK1 and ENaC.
In type 2 diabetes mellitus, insulin insensitivity results
in fluctuating levels of hyperglycaemia, and in extreme
cases; glucosuria. Previous reports have already
established the deranged transcriptional regulation of
SGK1 in response to hyperglycaemia [10]. These elevated
circulating levels of glucose have also been associated
with the release of a number of growth factors and
cytokines known to be involved in promoting the
pathogenesis of diabetic nephropathy, amongst these is
the Transforming Growth Factor-β1 (TGF-β1) [11-14].
Hyperglycaemic-induced TGF-β1 formation together with
osmotically-driven increases in SGK1 [15-17] provide a
link between poorly controlled plasma glucose and the
development of excess ENaC-mediated Na+-resorption
that underlies secondary hypertension as seen in some
diabetics (reviewed in Marshall et al, 2004). In addition
to these glucose mediated effects on TGF-β1 driven by
numerous factors including PKC [18] and the cell volume
regulatory responses to cell shrinkage initiated as a result
of hyper-osmotic stress , glucose is also known to acutely
increase the concentration of intracellular calcium
([Ca2+]i) in rat proximal tubular cells [19]. How these
calcium induced changes evoke alterations in both SGK1
and ENaC expression in human cortical collecting duct
(HCD) remains to be elucidated. Consequently, whilst
there is considerable evidence relating high glucose levels
to deranged sodium resorption in the kidney, the
mechanisms by which these elements come together to
promote the pathophysiological changes characteristic of
diabetic nephropathy requires further clarification.
In the current study we have used a novel model in
vitro system to assess the effect of high glucose,
TGF-β1 and cytosolic Ca2+ on SGK1 and ENaC
expression. We have correlated these changes to single-
cell determination of [Na+]i and suggested a potential
series of events that may explain why deregulated Na+
re-uptake may have dramatic repercussions for normal
kidney function, contributing to the pathogenesis of
secondary hypertension associated with diabetic
nephropathy in type 2 diabetes mellitus.
Materials and Methods
Cell Culture
HCD cells were derived from normal human kidney cortex
and immortalized with SV-40 virus. Clones were selected using
the monoclonal antibody, Ab272, which specifically recognizes
collecting duct principal cells [20]. HCD cells (passages 18-30)
were maintained in DMEM/Hams F-12 medium (GIBCO,
Invitrogen), supplemented with 2% fetal calf serum (FCS),
glutamine (2mmol/l), 15mmol/l HEPES, transferrin (5µg/ml),
Na2SeO3 (5ng/mL), insulin (5µg/ml) and dexamethasone
(5x10 –8 M). Cells were grown at 37°C in a humidified atmosphere
of 5% CO2 in air. For glucose experiments, cells were treated
with 5mM or 25mM glucose in the presence of unsupplemented
DMEM/Hams F-12 without FCS for time periods of 0, 24 and 48
hours following FCS-deprivation overnight. Basal (5mM)
glucose culture media was generated by mixing DMEM (0mM
glucose) with HAMS F-12 (10mM glucose). For TGF-β1 and
Ionomycin experiments, cells were treated with either TGF-β1
(2nM) or ionomycin (1µM) in the presence of DMEM/Hams F-
12 without FCS for periods of 4, 6, 8, 12 and 24 hours. For
sodium experiments, cells were seeded onto 3-Amino-
propyltriethoxy-silane (APES) (Sigma, Poole, UK) treated
coverslips and used within 1 day of plating.
Analysis of mRNA expression
RNA was prepared from 80% confluent HCD cells by acid-
guanidinium extraction [21] using a genelute mammalian total
RNA miniprep kit (Sigma) following the manufactures
instructions. Complementary DNA was synthesized by reverse
transcription using a Promega Reverse Transcription System
following an adapted method. Briefly, 1µg of total RNA and
0.5µg of random hexamers, in a final volume of 11µl, were
incubated at 70°C for 5 minutes, and then allowed to cool slowly
to 25°C. Primer extension was then performed at 37°C for 60
minutes following the addition of 1x (final concentration)
reaction buffer, containing 50mmol/l Tris-HCl (pH 8.3),
50mmol/l KCl, 10mmol/L MgCl2, 10mmol/l dithiothreitol and
0.5mmol/l spermidine, 1mmol/l (final concentration) of each
dNTP, 40U of rRNAsin ribonuclease inhibitor and 15U of AMV
reverse transcriptase in a final volume of 20µl. The RT mixture
was heated to 95°C for 5 minutes, then 4°C for 5 minutes. An
aliquot of 4µl was used in subsequent polymerase chain reaction
(PCR) reactions.
PCR amplification of cDNAs
Amplification of specific cDNAs was carried out using
the primers listed in Table 1. PCR reactions (20µl) were set up
containing 1.5mmol/l MgCl2, 0.2mmol/l of each dNTP, 0.5µM of
each primer and 1U of Taq DNA polymerase (Bioline).
Amplification of samples was performed using an initial
denaturation step of 95°C (5 minutes) followed by either 35
cycles (SGK1) (TGF-β1), 30 cycles (αENaC) consisting of one
minute of denaturing at 95°C, one minute of annealing at the
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Table 1. Polymerase chain reaction (PCR) primers used to amplify SGK1 and αENaC mRNA.
F = forward primer, R = reverse primer.
required temperature and a one minute extension at 72°C. A
final elongation step of 72°C for seven minutes was included in
all PCR amplifications.
Analysis of protein expression
The preparation of cytosolic proteins and their
subsequent separation by gel electrophoresis and electro-
blotting onto Immobilon P membrane (Millipore, Watford,UK)
were as described previously [22]. Briefly proteins (5µg) were
separated by sodium dodecyl sulphate (SDS) polyacrylamide
gel electrophoresis (4.5% stacking gel, 7.5% or 10% resolving
gel) at 200volts for 50 minutes in electrophoresis buffer
containing 25mmol/l Tris, 192mmol/l glycine and 0.1% (wt/vol)
SDS. Proteins were transferred onto Immobilin P membrane  in
transfer buffer (25mmol/lTris, 192mmol/l glycine, 20% (vol/vol)
methanol) for 1 hour at 100 volts; 4°C. Following protein
transfer, membranes were blocked in PBS-T (PBS plus 0.1%
Tween-20) containing 20% (wt/vol) nonfat milk powder (Marvel,
Premier Brands, Stafford, UK) for 1 hour at 25°C and then
washed with PBS-T for 15 minutes. Filters were analyzed with
specific polyclonal antibodies against human SGK1 (The
Binding Site) anti-human αENaC (Affinity Bioreagents) and
anti-TGF-β1 (Santa Cruz) at a dilution of 1:3000 + 0.01% milk,
1:600 and 1:500 respectively. After three 10 minute washes in
PBS-T, the membranes were incubated with the secondary
antibody (horseradish peroxidase- conjugated) anti-rabbit
(αENaC diluted 1:2000, TGF-β1 diluted 1:40,000) and anti-sheep
(SGK1 diluted 1:30000) in PBS-T (0.05%) for 60 minutes at 25oC
followed by three 10 minutes washes in PBS-T. Specific proteins
were detected using ECL detection reagent chemiluminescence
system (Amersham Biosciences) and were visualized after
exposure of membranes to X-ray film for 1-10 minutes. Control
experiments were included where primary antibody was omitted,
and filters were exposed to secondary antibody and ECL
detection. All blots were probed with GAPDH (Biogenesis, UK)
diluted at 1:20,000 to control for protein loading in subsequent
densitometry analysis of expression levels.
Immunocytochemistry
Cells were allowed to grow to 80% confluence on APES
treated coverslips and then fixed in 4% paraformaldehyde
(PFA). Non-specific binding was prevented by blocking for 1
hour at 25oC in PBS + 0.01% triton X-100 containing 10% normal
goat serum. Following three 10 minute washes with PBS, the
nuclear stain DAPI (4’,6-diamidino-2-phenylindole,
dihydrochloride; 1mmol/L) was added to each coverslip for 3
minutes. After washing with PBS (3x5 minutes), cells were
incubated with the cytoskeletal stain TRITC-conjugated-
Phalloidin (Sigma) diluted at 1:100 in PBS supplemented with
0.01% Triton X-100 for 1 hour at 25°C. Following further washing
(3x5 minutes), cells were incubated overnight at 4°C with the
corresponding primary antibody (anti-αENac, anti-SGK1)
diluted in PBS + 0.01% Triton X-100. Following antibody
incubation, cells were washed with PBS and then incubated in
Alexa 488 conjugated goat anti-rabbit (αENaC ) or goat anti-
sheep (SGK1) for 1 hour at 25°C. Secondary antibodies
(Molecular Probes) were diluted (1:400) in PBS + 0.01% Triton
X-100. After 1 hour, cells were washed 3x10 minutes and
coverslips mounted in citifluor (glycerol/PBS solution: Agar
Scientific) on glass slides.
Single cell Microfluorimetry
HCD cells seeded and grown overnight on APES-coated
coverslips were loaded with 20 µl of the Na+-fluorophore SBF/
Pluronic acid (20%) (Sigma). Cells were incubated for 90 minutes
in a humidified atmosphere (5% CO2) at (37°C). HCDs are a
polarized, epithelial cell model, which compensate Na+ influx
via apical epithelial sodium channels with Na+ efflux at the
basolateral pole via a Na+/K+ ATPase. Therefore in order to
resolve small changes in cytosolic Na+ concentration it was
necessary to debilitate extrusion mechanisms in both control
and experimental conditions. Cells were incubated with the Na+/
K+ ATPase pump inhibitor Ouabain (100µM) for the last 30
minutes of the incubation period. To determine whether the
acute application of glucose had an effect on [Ca2+]i cells were
loaded with 2.5µM of the Ca2+-fluorphore fura-2/AM (30
minutes, 37°C; Sigma).
Coverslips were washed and placed in a steel chamber,
the volume of which was approximately 500µl. A single 22mm
coverslip formed the base of the chamber, which was mounted
into a heating platform on the stage of an Axiovert 200 Research
Inverted microscope (Carl Zeiss Ltd., Welwyn Garden City, UK).
All experiments were carried out at 37°C using unsupplemented
DMEM/Hams F-12 as the standard extracellular medium. Cells
were illuminated alternatively at 340nm and 380nm using a
Metaflour imaging workbench (Universal Imaging Corp Ltd.,
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Marlow, Bucks, UK). Emitted light was filtered using a 510nm
long-pass barrier filter and detected using a Cool Snap HQ
CCD camera (Roper Scientific). Changes in the emission
intensity of SBF and fura-2 expressed as a ratio of dual excitation
were used as an indicator of changes in [Na+]i using established
procedures. Data was collected at 3 second intervals for multiple
regions of interest in any one field of view. All records have
been corrected for background fluorescence (determined from
cell-free coverslip).
Data Analysis
Autoradiographs were quantified by densitometry
(TotalLab 2003). Statistical analysis of data was performed using
a one-way ANOVA test with a Tukey’s Multiple Comparison
post-test. Data are expressed as arithmetic mean ± SEM and n
denotes the number of experiments and P<0.05 signifies
statistical significance.
Results
Expression of SGK1, αENaC and TGF-β1  in
HCD cells
Studies confirmed the presence of SGK1, αENaC
and TGF-β1 mRNA and protein in HCD cells. RT-PCR
analysis of several RNA preparations from HCD cells
revealed PCR products representative of SGK1, αENaC
and TGF-β1 mRNA (figure 1A, 1C and 1E respectively).
To confirm that mRNA was appropriately translated,
Fig. 1. Expression of SGK1, αENaC and
TGF-β1 mRNA and protein in HCD-cells.
Panels A, C and E represent RT-PCR analyses
using primers specific for human SGK1,
αENaC and TGF-β1. PCR products of 597bp,
618bp and 340 bp were observed in three
RNA preparations (1, 2 and 3) corresponding
to mRNA expression for SGK1, αENaC and
TGF-β1 respectively in HCD cells. Negative
controls included both water and samples in
which AMV enzyme had been omitted from
the reverse transcription reaction (data not
shown). Western blot analyses of HCD cell
lysates (panels B, D and F, 5µg protein/lane)
using an antibody against human SGK1
(panel B, -), αENaC (panel D, -) and TGF-β1
(Panel F, -) confirmed the presence of the
protein in HCD cells. A protein band of
approximately 50kDa (SGK1), 75Da (αENaC)
and 45 kDa (TGF-β1) was detected. Controls
included SGK1 (panel B +), αENaC
(panel D +) and TGF-β1 (Panel F +) antibody
pre-absorbed with a 10-fold excess of
immunizing peptide.
protein expression was determined by Western blotting
(figures 1B, 1D and 1F). Western blot analyses revealed
bands at approximately 50kDa, 75kDa and 45kDa,
representative of those expected for SGK1, αENaC and
TGF-β1 respectively.
The effect of glucose on the localisation of SGK1
and αENaC
The distribution of SGK1 and αENaC in HCD cells
was examined by immunocytochemistry. SGK1 protein
was principally localised to the cytosol (figure 2 A/2),
whilst αENaC immunoreactivity appeared to be
predominantly nuclear (figure 2 C/2). Following 48 hour
incubation with high glucose (25mM) SGK1 redistributed
into the nucleus (figure 2 B/2) whilst αENaC was found
in both the nucleus and the cytoplasm under identical
conditions (figure 2 D/2).
Up-regulation of SGK1 and αENaC expression
in high glucose
To examine the effect of elevated glucose on SGK1
and αENaC expression, HCD cells were incubated in
high glucose (25mM) for 24 and 48 hours. Cells grown
under these conditions exhibited increased SGK1
expression to 185 ± 18.8% of control (5mM) at 24 hours
and to 261.8 ± 5.7% of control at 48 hours (n=3, P<0.01;
see figure 3 A and B). HCD cells grown under high
A
C
E
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Fig. 2. Altered localization of SGK1
and αENaC in response to high
glucose. SGK1 immunoreactivity in
HCD-cells following a 48hr culture is
shown in row A (5mM glucose) and B
(25mM glucose), whilst αENaC
immunoreactivity is shown in row C
(5mM glucose) and D (25mM glucose)
over the same 48hr time interval.
Column 1 demonstrates nuclear
staining (DAPI; blue); column 2
illustrates either SGK1 (A and B) or
αENaC (C and D) immunoreactivity
(localized using Alexa 488; green).
Column 3 depicts an overlay image.
Note the intense cytosolic localization
of SGK1 at sub-stimulatory glucose
concentrations. SGK1 re-distributes to
the nucleus in response to elevated
(25mM) glucose. The localization of
αENaC is primarily nuclear under
resting conditions, and becomes more
cytosolic in response to high glucose.
glucose conditions also exhibited increased αENaC
expression at both 24 and 48 hours. This increase in protein
expression amounted to 144 ± 8.0% of control (5mM) at
24 hours and 167.4 ± 11.2% of control at 48 hours
(n=3, P<0.01; see figure 3 C and D).
Up-regulation of TGF-β1 expression in high
glucose
To examine the effect of elevated glucose on TGF-
β1 expression, HCD cells were incubated in high glucose
(25mM) for 24 and 48 hours. Cells grown under these
conditions exhibited increased TGF-β1 expression to 130
± 16.7% of control (5mM) at 24 hours and to
187.7 ± 15.8% of control at 48 hours (n=3, P<0.01; see
figure 4 A and B).
Up-regulation of SGK1 expression in response
to elevated calcium levels and TGF-β1
Previous reports have suggested that raised [Ca2+]i
and increased circulating levels of the cytokine TGF-β1
play a role in the patho-physiology of hyperglycaemia. In
the current study 25mM glucose was found to evoke a
rise in TGF-β1 expression at 48 hours, 187.7 ± 8.4% of
control (n=3, P<0.01; data not shown). The glucose-
evoked up-regulation of SGK1 has been linked to these
signaling intermediates [23]. Treatment of HCD cells with
the Ca2+ ionophore ionomycin (1µM see figure 5Aand B)
significantly increased SGK1 expression to 262 ± 6.0%
of control at 6 hours and 263 ± 22.8% of control at
8 hours (n=3, P<0.01), with expression levels returning
to near basal by 24 hours. However the effect of
TGF-β1 ( figure 5C and D) was less potent with
expression only increased at 8 hours 128 ± 13% as
compared to control (n=4, P<0.01). Co-application of
TGF-β1 and ionomycin failed to augment the change in
expression, (data not shown).
Up-regulation of αENaC expression in response
to elevated calcium levels and TGF-β1
Treatment of HCD cells with ionomycin (1µM)
resulted in increased αENaC expression levels to
175 ± 5.5% of control at 6 hours (figure 6A and B, n=3;
P<0.01). Whilst expression was clearly elevated above
basal levels at both 4 (135 ±1.0%) and 8 hours
(136 ± 7.3%) expression was not found to be statistically
significant. The administration of TGF-β1 also elicited a
A
B
C
D
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stimulatory effect over αENaC expression at 6 hours,
159.7 ± 9.8% (figure 6C and D, n=3; P<0.01) as
compared to control. Co-application of TGF-β1 and
ionomycin failed to augment the change in expression,
(data not shown). Together, these data suggest a role for
both [Ca2+]i and TGF-β1 in the regulation of SGK1 andαENaC protein expression.
HCD-cells exposed to high glucose exhibit
increased [Na+]i and [Ca
2+]i.
Acute (5 minute) application of glucose (20mM)
evoked a small and sustained increase in [Ca2+]i (27 cells
in 4 separate experiments). The effect was identical to
that produced by a comparable concentration (20mM) of
mannitol (33 cells in 4 separate experiments), used to
control for the osmotic effect of high glucose.
Intracellular sodium levels were found to be
significantly elevated following 24 (113.1 ± 1.0%) and 48
(114 ± 1.1%) hours exposure to 25mM glucose, as
compared to cells cultured in low (5mM) glucose (n=3
P<0.01, see figure 7). This data taken in conjunction with
that described previously suggest that increases in [Na+]i
expression in response to high glucose after 48 hours may
be mediated via the increased expression of both SGK1
and αENaC.
Fig. 3. Up-regulation of SGK1 and αENaC and protein expression in response to high glucose. HCD-cells were incubated in
5mM and 25mM glucose for 24 and 48 hours. (A) Representative Western blot analysis using an anti-SGK1 antibody (B) analysis
of changes in SGK1 protein expression. Results represent mean ± SEM; n=4; ** P< 0.01. (C) Representative Western blot
analysis using an anti-αENaC antibody (D) analysis of changes in αENaC protein expression. Results represent mean ± SEM;
n=4; ** P < 0.01.
Fig. 4. Up-regulation of TGF-β1 protein expression in response
to high glucose. HCD-cells were incubated in 5mM and 25mM
glucose for 24 and 48 hours. (A) Representative Western blot
analysis using an anti-TGF-β antibody (B) analysis of changes
in TGF-β1 protein expression. Results represent mean ± SEM;
n=6; * P <0.05, ** P < 0.01.
A
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Fig. 5. Treatment of HCD cells with ionomycin and TGF-β1 results in increased SGK1 protein expression. HCD cells were
incubated with either ionomycin (1µM) or TGF-β1 (2nM) for incubation periods of 4, 6, 8 12 and 24 hours. (A and C) Representative
Western blot analysis using an anti-SGK1 antibody (B and D) analysis of changes in SGK1 protein expression. Results represent
mean ± SEM; n=4; ** P < 0.01.
Fig. 6. Treatment of HCD cells with ionomycin and TGF-β1 results in increased αENaC protein expression. HCD cells were
incubated with either ionomycin (1µM) or TGF-β1 (2nM) for incubation periods of 4, 6, 8 12 and 24 hours. (A and C) Representative
Western blot analysis using an anti-αENaC antibody (B and D) analysis of changes in αENaC protein expression. Results
represent mean ± SEM; n=4; ** P < 0.01, *** P < 0.001.
Discussion
Exposure of renal epithelial cells to changes in
osmolality necessitates the initiation of cell volume
regulatory processes, activation of which serves to restore
cell volume preserving both integrity and function. Inability
to resolve these changes may have serious repercussions
for sodium transport and the development of secondary
hypertension associated with renal diseases such as
diabetic nephropathy. In the current study we have used
a model in vitro system of the human cortical collecting
duct (HCD) to investigate expression of key recognition
A
B
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signaling elements involved in Na+ reabsorption under
control and high glucose conditions.
We present data confirming mRNA and protein
expression of the serum and glucocorticoid inducible
kinase (SGK1) and the α conducting subunit of the
epithelial sodium channel (ENaC) in HCD-cells.
Incubation with glucose, the Ca2+-ionophore ionomycin
and the cytokine TGF-β1 were all found to evoke a time-
dependent increase in both SGK1 and αENaC protein
expression. These molecular changes, seen under
conditions of high glucose, were correlated to an increase
in Na+-uptake at the single-cell level. High glucose also
alters the cellular localization of both SGK1 and αENaC.
Together these data offer a potential explanation for
glucose-evoked Na+-resorption and the contributory role
of SGK1 and ENaCs in development of secondary
hypertension, commonly linked to diabetic nephropathy.
Transfer of information regarding the osmotic state
of the duct depends largely on cell-to-cell coupling.
Consequently, changes in intercellular communication may
play a key role in transducing changes in osmolarity to
appropriate changes in absorption.
We have recently reported that HCD-cells express
the mechano-sensitive transient receptor-potential
channels, TRPV4 [24]. These channels respond to
osmotic perturbations by allowing Ca2+-entry and store-
mobilization, a pre-requisite for initiation of a regulatory
volume decrease [25. 26], instigated following exposure
to hypo-osmotic stress to aid cell volume recovery [27].
Resultant Ca2+-signals are rapidly synchronized across
coupled cells via connexin-43-mediated gap-junctions
[24]. However, cytosolic Ca2+ does not merely
synchronize cellular activity between HCD-cells.
Hyperglycaemia has been associated with elevated
Fig. 7. HCD cells exposed to elevated levels of glucose
exhibit increased intracellular sodium levels. HCD cells
were incubated in 5 or 25mM glucose for 24 and 48 hours.
Cells were then pre-incubated with the Na+/K+ ATPase
inhibitor Ouabain. Basal levels of intracellular Na+ were
measured in SBF-1/pluronic loaded HCD cells and
variability in [Na+]i between glucose treatment was
assessed. Data represent mean±SEM, n=3; ** P < 0.01.
cytosolic calcium in a number of diverse cell types from
both animal and human models of diabetes [19, 28, 29].
In the present study, acute application of glucose (20mM)
evoked a small, but sustained increase in cytosolic calcium
in HCD-cells, whilst direct elevation of [Ca2+]i via
ionomycin treatment significantly increased SGK1 protein
expression after 6-8hrs, a finding consistent with previous
studies in DAN-G pancreatic tumor cells [30]. Similarly,
glucose-mediated SGK1 transcription in 3T3 mouse
fibroblasts is reportedly abolished in the presence of the
calcium channel blocker nifedipine [10]. The metabolism
of glucose can be ascribed to a number of pathways which
are all interlinked [31]. In addition to evoking increases in
[Ca2+]i, glucose also increases the de novo synthesis of
diacylglycerol (DAG) eliciting downstream activation of
protein kinase C/mitogen activated protein kinase (PKC/
MAPK) [32]. PKC has emerged as a potential regulator
in the development and progression of diabetic
nephropathy and reportedly plays a key role in TGF-β
expression through its actions on the transcription factor
complex AP-1 [33]. In accordance with previous
literature, elevated [Ca2+]i and signalling molecules arising
from glycolytic intermediates, may regulate transcriptional
control of SGK1 as downstream components of the
hyperglycaemic response.
In the current study high glucose elevates TGF-β1
expression at 24 and 48 hours. TGF-β1 is a multifunctional
cytokine known to be increased in type 2 diabetics and is
thought to be involved in the development of renal
hypertrophy and excessive matrix deposition, implicating
this cytokine as a key mediator in the development of
diabetic nephropathy [34-36]. TGF-β1 reportedly alters
SGK1 gene transcription [10], an effect believed to be
mediated via p38 MAPK [15, 17]. This may further
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exacerbate glucose-evoked cell hypertrophy, highlighting
a possible link between elevated levels of circulating
glucose and increased expression of SGK1. This
relationship is supported in the current study by our
observed changes in SGK1 expression following
exogenous application of the cytokine, an effect known
to be reduced in the presence of a TGF-β neutralizing
antibody [10]. The temporal relationship between Ca2+
and TGF-β-evoked increases in SGK1-expression are
consistent with previous reports highlighting a causative
link between these key signaling elements [10]. It is well
established that glucose increases the expression of TGF-
β1 [12, 13, 37], and TGF-β1 increases expression of the
insulin-independent GLUT 1 glucose transporter [38].
Consequently, GLUT1-mediated increases in TGF-β1
expression will promote and further exacerbate the rate
of glucose uptake under conditions of hyperglycaemia,
contributing to the pathogenesis of diabetic nephropathy.
This feed forward build up of TGF-β1 may provide the
link between gluco-toxicity and cell dysfunction in diabetic
nephropathy, with TGF-β1 mediating glucose-evoked
cellular hypertrophy whilst stimulating matrix biosynthesis
[39], two hallmarks of diabetic renal disease.
Whilst the transient nature of the TGF-β1-evoked
response may reflect glucose toxicity associated with
exogenous application of high concentrations of the
cytokine, perforation of the cell membrane by the Ca2+-
ionophore is likely to have multiple non-specific effects
that ultimately impair cell function. These effects may
explain why SGK1-expression appears to respond to
changes in Ca2+ and TGF-β1 before elevated glucose,
even though both are downstream of hyperglycaemia.
SGK1 promotes Na+ re-uptake via the epithelial
sodium-channel (ENaC). This heterotrimeric channel
resides in the cytoplasm; bound to Nedd 4.2, [40], and is
comprised of an α, β and γ subunit, of which only the
α-subunit is required for formation of a fully functional
channel. Phosphorylation of SGK1 via a PI3-K dependent
pathway facilitates binding of Nedd 4.2 to SGK1, thereby
dissociating the Nedd 4.2/ENaC complex. This
dissociation reduces ENaC degradation and facilitates
translocation and insertion of the channel into the cell
membrane [8]. The association between SGK1 and
ENaC leads us to assume that these glucose-, Ca2+- and
TGF-β1-evoked changes in αENaC should mimic those
already reported for SGK1, an assumption supported by
the current study. The net effect of altered ENaC-
expression would be an increase in Na+-resorption. It
seems reasonable therefore to assume that any glucose-
evoked increase in αENaC expression may result from
reduced degradation, as opposed to increased gene
transcription. Although at the single-cell level these
changes in Na+ re-uptake are small, across the epithelium,
they offer a potential mechanism to explain how high
glucose may lead to the development of secondary
hypertension commonly seen in diabetic nephropathy [41].
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